As of September 13, 2026, the hair relaxer MDL (No. 3060, before Judge Mary M. Rowland in the Northern District of Illinois) has grown to 11,779 pending cases as of late August 2026, out of more than 16,000 filed overall. The ten court-selected bellwether cases remain in expert discovery, which runs through November 16, 2026, with dispositive motions due December 16, 2026 and briefing continuing into February 2027. A defense motion seeking to exclude plaintiffs’ general-causation experts has been fully briefed since June 2026 but remains undecided. No trial date has been set, and the first bellwether trials are now widely expected in 2027 rather than 2026.
Last updated: September 2026
The hair relaxer lawsuit is moving fast in 2026, with bellwether trials scheduled, new defendants fighting discovery, and thousands of women waiting for answers. This is the most important hair relaxer lawsuit update you will read this year.
The case targets major beauty brands that sold chemical relaxers linked to uterine cancer, endometrial cancer, and ovarian cancer. The science, the court filings, and the money are all in motion right now.
This article covers exactly where the lawsuit stands in 2026. You will learn who qualifies, what the trials mean, how much victims might receive, and what steps to take if you think you have a claim.
One fact that sets the stage: a landmark 2022 study published in the Journal of the National Cancer Institute found that women who used chemical hair straighteners more than four times per year faced more than double the risk of uterine cancer compared to those who never used them.
Hair Relaxer Lawsuit Update: Where Things Stand Right Now
The hair relaxer lawsuit in 2026 is one of the most active mass tort cases in the U.S. federal court system. Hundreds of cases are consolidated inside a single MDL, and the litigation is approaching its most critical phase yet.
MDL No. 3060 is pending in the Northern District of Illinois before Judge Mary M. Rowland. As of 2026, the court has cleared significant pretrial hurdles. Discovery has produced millions of documents. Expert witnesses on both sides have been deposed.
The defendants are fighting hard. They argue that the science does not firmly establish causation between their specific products and the cancers named in the lawsuits. Plaintiffs disagree, and the bellwether trials are where this argument will be tested in front of a jury.
| Key Case Detail | Information |
|---|---|
| MDL Name | In re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation |
| MDL Number | MDL No. 3060 |
| Case Number | 1:23-cv-00818 |
| Presiding Judge | Judge Mary M. Rowland |
| Court | U.S. District Court, Northern District of Illinois |
| Year Active | 2023 to present (active through 2026) |
| Number of Cases | Several thousand and growing |
The outcome of the bellwether trials in 2026 will shape whether this litigation ends in a global settlement or continues to full-scale trial on a case-by-case basis.
Hair Relaxer Lawsuit 2026: The Biggest Developments This Year
2026 is shaping up to be a defining year for this litigation. The pretrial phase is largely behind the parties, and the focus has shifted to trial preparation and settlement pressure.
Judge Rowland has pushed both sides to narrow their expert witness lists and finalize the Daubert challenges, which are legal hearings that determine whether expert testimony is scientifically reliable enough to go before a jury. This process has direct consequences for plaintiffs. If the court allows causation experts to testify, the cases are significantly stronger.
Several pretrial motions for summary judgment were filed by defendant companies in late 2025 and early 2026. These motions ask the judge to dismiss cases before trial by arguing plaintiffs lack sufficient evidence. The court’s rulings on these motions are being watched closely.
Key 2026 developments to know:
- Bellwether trial selections confirmed for scheduling
- Daubert hearings on plaintiff causation experts completed or underway
- Defense summary judgment motions pending or decided
- Settlement negotiations reportedly occurring behind the scenes
- Plaintiff steering committee actively coordinating thousands of claims
Think of this phase like jury selection week before a big criminal trial. The outcome of the week before often determines what happens in the courtroom itself.
Hair Relaxer Lawsuit Updates: New Filings and Case Growth
New cases are still being filed in 2026, which tells you something important: attorneys believe the litigation has real merit and real settlement value.
The MDL continues to grow as more women come forward with diagnoses connected to years of relaxer use. Women who were diagnosed with uterine cancer between 2015 and 2024 and used chemical relaxers regularly are the core of the plaintiff pool.
Amended complaints have also been filed in 2026 naming additional defendants and adding product lines that were not included in early filings. The net is widening.
Recent filing trends in 2026:
- New cases added to MDL weekly
- Amended complaints targeting additional corporate entities
- Multi-defendant cases increasing as product use histories span multiple brands
- Cases filed on behalf of estates of deceased plaintiffs also being accepted
| Filing Category | Status in 2026 |
|---|---|
| New individual cases | Actively being accepted |
| Amended complaints | Filed and pending |
| Multi-brand use cases | Growing portion of the MDL |
| Estate/posthumous claims | Accepted in many jurisdictions |
Key Takeaway: The hair relaxer lawsuit is not slowing down in 2026. It is growing, heading toward trial, and new filings are still being accepted across the country.
Hair Relaxer MDL Update 2026: How the Multidistrict Litigation Works
The MDL structure is what makes this case so powerful. MDL stands for multidistrict litigation, and it means that thousands of individual lawsuits filed across the country are pulled together before one judge for pretrial coordination.
This is not a class action lawsuit. That distinction matters a lot. In a class action, everyone gets the same settlement. In an MDL mass tort, each plaintiff’s case is evaluated individually. Your payout depends on your specific diagnosis, your product use history, and your documented harm.
Judge Rowland controls pretrial motions, discovery, expert witnesses, and the bellwether trial schedule. Once bellwether trials produce verdicts, both sides usually use those results to negotiate global settlements for the remaining cases.
The MDL process tends to move in phases:
| MDL Phase | Description | 2026 Status |
|---|---|---|
| Phase 1: Filing and Transfer | Cases filed and transferred to MDL court | Complete |
| Phase 2: Discovery | Document production, depositions | Largely complete |
| Phase 3: Expert Testimony | Daubert challenges, expert reports | Active in 2026 |
| Phase 4: Bellwether Trials | First test trials before juries | Scheduled in 2026 |
| Phase 5: Settlement or Trial | Global resolution or continued trials | Anticipated late 2026 or 2027 |
One thing the MDL structure does well is share the cost of litigation. Expert witnesses, scientific studies, and document review are expensive. By pooling resources, plaintiffs’ attorneys can fund a case against billion-dollar corporations.
Hair Relaxer Lawsuit Bellwether Trials: What They Mean for Your Case
Bellwether trials are test cases. A small number of individual cases, typically three to six, are selected from the larger MDL to go to trial first.
The results of those trials do not legally bind anyone else’s case. But they do something arguably more important: they show both sides what a jury is likely to do. A plaintiff verdict in a bellwether trial puts enormous pressure on defendants to settle. A defense verdict puts pressure on plaintiffs to accept lower offers or prepare for a long fight.
In 2026, the hair relaxer MDL bellwether trial cases are being selected and scheduled. The cases chosen tend to represent the strongest and most typical claims in the pool, not outliers.
What makes a case a strong bellwether candidate:
- Clear, documented product use history spanning multiple years
- Diagnosis of a qualifying cancer with a confirmed medical record
- No significant confounding factors (other major cancer risk factors)
- A plaintiff who is able to testify and tell a compelling story
- Strong causation expert testimony to support the claim
The bellwether trial results will almost certainly drive the settlement conversation. If plaintiffs win two or three of the first bellwether trials, expect global settlement discussions to accelerate dramatically.
Hair Relaxer Lawsuit Trial Date 2026: What the Schedule Looks Like
As of 2026, bellwether trial dates have been discussed in court scheduling orders for the hair relaxer MDL. Specific trial dates are subject to judicial scheduling and can shift based on pretrial motion outcomes.
Judge Rowland has indicated that moving toward trial is a priority. The court has set firm deadlines throughout the pretrial process to keep things on track.
Anticipated 2026 trial schedule framework:
| Milestone | Anticipated Timing |
|---|---|
| Daubert ruling on causation experts | Early to mid-2026 |
| Summary judgment rulings | Mid-2026 |
| Bellwether trial case selections finalized | Mid-2026 |
| First bellwether trial begins | Late 2026 (tentative) |
| Settlement discussions (if triggered by verdicts) | Late 2026 into 2027 |
It is worth being clear: trial dates in MDL litigation shift. Judges manage hundreds of complex motions simultaneously. A single discovery dispute or expert challenge can push a trial date by months.
But the direction is clear. 2026 is the year this case goes from a pretrial file to a courtroom reality.
Key Takeaway: The bellwether trial schedule is the single most important thing to watch in 2026. Those verdicts will determine how much everyone else gets, and how fast.
Hair Relaxer Cancer Lawsuit Update: The Science Driving the Case
The science behind the hair relaxer cancer lawsuit is what separates this litigation from speculative claims. Real, peer-reviewed research is driving these cases forward.
The most cited study comes from the National Institute of Environmental Health Sciences (NIEHS). Published in 2022, the study followed more than 33,000 women over about 11 years. Women who used chemical hair straighteners more than four times per year were 2.5 times more likely to develop uterine cancer than non-users.
That is a staggering number. For context, smoking increases lung cancer risk by about 15 to 30 times, so 2.5 times may sound modest, but uterine cancer rates in this country have been rising steadily, and this association explains part of why.
Key chemicals identified in the research:
- Phthalates: hormone-disrupting compounds found in fragrance and plasticizers
- Parabens: preservatives linked to endocrine disruption
- Bisphenol-A (BPA): found in some product packaging, linked to hormonal effects
- Formaldehyde-releasing agents: present in some straightening formulas
- Cyclosiloxanes: linked to reproductive toxicity in laboratory studies
Defendants argue that correlation is not causation. Plaintiffs’ experts counter that the biological mechanism is plausible and the epidemiological data is consistent.
Who Qualifies for the Hair Relaxer Lawsuit?
You may qualify for the hair relaxer lawsuit if you used chemical hair relaxers regularly and were later diagnosed with a qualifying cancer.
The basic eligibility requirements center on product use and medical diagnosis. You do not need to remember exact brand names, though it helps. You do need a documented cancer diagnosis and some evidence of product use over time.
Core eligibility criteria:
- Used chemical hair relaxer products at least four or more times per year for a period of years
- Received a diagnosis of uterine cancer, endometrial cancer, or ovarian cancer
- Used products made by one or more of the named defendant companies
- Diagnosis occurred after years of regular product use (not before)
| Eligibility Factor | Requirement |
|---|---|
| Product use frequency | 4+ uses per year, sustained period |
| Qualifying conditions | Uterine cancer, endometrial cancer, ovarian cancer |
| Named defendants’ products | At least one brand from the defendant list |
| Diagnosis timing | After documented period of regular use |
| Statute of limitations | Varies by state, typically 2 to 3 years from diagnosis or discovery |
If you are unsure whether your situation qualifies, the key is not to self-eliminate. Many women dismiss themselves before speaking to an attorney, only to learn later they had a viable claim.
Hair Relaxer Lawsuit Eligible Conditions: Which Diagnoses Qualify?
The three primary qualifying conditions in the hair relaxer litigation are uterine cancer, endometrial cancer, and ovarian cancer.
Uterine and endometrial cancers are closely related. Endometrial cancer begins in the lining of the uterus and is technically a type of uterine cancer. Both are covered. Ovarian cancer is also included based on research linking endocrine-disrupting chemicals to ovarian tumor development.
Some law firms are also reviewing claims involving uterine fibroids, though that condition carries a lower case value and different evidentiary standards than cancer diagnoses.
Qualifying diagnosis breakdown:
| Condition | Covered? | Research Support |
|---|---|---|
| Uterine cancer | Yes, primary | Strong (NIEHS 2022 study) |
| Endometrial cancer | Yes, primary | Strong (same study) |
| Ovarian cancer | Yes, included | Moderate (additional studies) |
| Uterine fibroids | Reviewed case-by-case | Some support, lower tier |
| Cervical cancer | Generally not included | Limited evidence link |
| Breast cancer | Generally not included | Limited evidence link |
Key Takeaway: The strongest claims involve uterine or endometrial cancer diagnoses combined with documented, long-term use of relaxer products from named defendant brands.
Uterine Cancer Hair Relaxer Lawsuit: Why This Condition Is Central
Uterine cancer is the primary diagnosis driving the hair relaxer litigation, and for good reason. The NIEHS study published in the Journal of the National Cancer Institute specifically identified a 2.5-times elevated risk of uterine cancer in heavy relaxer users.
Uterine cancer is the most common gynecologic cancer in the United States. Rates have been rising over the past two decades, and researchers have pointed to environmental exposures, including endocrine-disrupting chemicals in personal care products, as part of the explanation.
Black women are disproportionately affected by this lawsuit. Research shows that Black women are more likely to use chemical hair relaxers and at higher frequency. They are also diagnosed with uterine cancer at rates roughly twice that of white women.
Uterine cancer and hair relaxer use: key data points:
- Women using relaxers 4+ times per year: 2.5x higher uterine cancer risk
- Uterine cancer diagnoses in the U.S. have risen by approximately 3% per year
- Black women represent approximately 60% of hair relaxer users in study populations
- Uterine cancer is the 4th most common cancer diagnosed in American women
The racial disparity angle is not lost on the courts or the media. Several plaintiffs have framed their claims partly as a consumer protection failure targeting communities that were never warned about these risks.
Endometrial Cancer Hair Relaxer Lawsuit: How These Cases Differ
Endometrial cancer claims function similarly to uterine cancer claims but with a specific focus on the uterine lining rather than the uterine wall.
The distinction matters medically and sometimes legally. Endometrial cancer is staged and graded differently than uterine sarcoma, for example. In terms of the hair relaxer lawsuit, endometrial cancer diagnoses are treated as primary qualifying conditions with full claim eligibility.
Women diagnosed with endometrial cancer who used chemical relaxers regularly have the same basic claim structure as uterine cancer plaintiffs. The key is showing the diagnosis, the product use, and the link through scientific evidence and expert testimony.
Endometrial cancer claim checklist:
- Confirmed endometrial cancer diagnosis with pathology report
- Medical records showing diagnosis date and stage
- History of chemical relaxer use, ideally documented by salon records, purchase records, or personal testimony
- Diagnosis occurring within the statute of limitations window for your state
- No prior history of endometrial cancer before relaxer use began
One challenge in these cases is that endometrial cancer has several known risk factors, including obesity, diabetes, and certain hormonal conditions. Defense attorneys will argue these alternative causes in every trial. Plaintiffs’ attorneys use expert witnesses to argue that relaxer use was a contributing cause even when other factors exist.
Hair Relaxer Brands in Lawsuit: Which Companies Are Named?
The hair relaxer lawsuit names multiple major consumer goods companies that marketed and sold chemical hair relaxer products for decades.
This is not a lawsuit against small or unknown companies. These are corporations with hundreds of millions to billions of dollars in annual revenue. That financial depth matters for settlement potential.
Primary defendants named in the litigation:
| Brand/Company | Products Involved |
|---|---|
| L’Oreal USA | Dark & Lovely, Soft Sheen-Carson line |
| Strength of Nature | Optimum, African Pride, TCB Naturals |
| Dabur International | ORS Olive Oil, Motions |
| Namaste Laboratories | Organic Root Stimulator products |
| Godrej Consumer Products | Soft & Beautiful, Just for Me |
| Revlon | Realistic, other relaxer lines |
Each company is fighting the lawsuit on its own timeline and with its own legal strategy. Some defendants may settle before others. A settlement by one company does not automatically resolve claims against others.
It is also worth knowing that if you used multiple brands over your lifetime, you may have claims against multiple defendants simultaneously. Your attorneys would apportion the claims accordingly.
L’Oreal Hair Relaxer Lawsuit Update: The Biggest Defendant in 2026
L’Oreal is the highest-profile defendant in the hair relaxer litigation, and its legal strategy in 2026 is drawing significant attention.
L’Oreal USA, which owns the Soft Sheen-Carson brand and the Dark & Lovely line, has faced some of the most claims in the MDL. The company has consistently denied that its products cause cancer and has invested heavily in defense expert witnesses to challenge the causation science.
In 2026, L’Oreal is actively contesting Daubert challenges and opposing summary judgment denials. The company has resources to fight this litigation for years. But mass tort history shows that even well-funded defendants eventually calculate that settlement is cheaper than trial after a series of adverse jury verdicts.
L’Oreal lawsuit status snapshot in 2026:
- Named defendant in thousands of individual MDL cases
- Defending on causation grounds (science does not prove their product caused cancer)
- No announced settlement as of 2026
- Daubert challenges and summary judgment motions active
- Continued active litigation through at least the first bellwether trial
The way L’Oreal resolves its cases, through trial loss, trial win, or settlement, will set a benchmark for how other defendants approach their own resolution strategy.
Key Takeaway: L’Oreal is the central defendant to watch in 2026. Its trial performance or settlement decision will define the financial outcome for thousands of plaintiffs across the entire MDL.
Hair Relaxer Lawsuit Settlement Amount: What Are Victims Expecting?
No official settlement has been announced as of 2026. But the litigation is close enough to trial that realistic estimates are beginning to surface in legal circles.
Mass tort settlements typically scale based on injury severity. The worse the diagnosis, the higher the expected payout. Younger plaintiffs with longer life expectancy losses tend to receive larger amounts. Plaintiffs with strong documented product use histories and clean medical records are positioned better than those with more complex medical backgrounds.
Based on comparable mass tort litigation (including talcum powder and IUD lawsuits), legal analysts have offered the following rough tier estimates:
Estimated settlement tier ranges (not guaranteed):
| Tier | Qualifying Condition | Estimated Range |
|---|---|---|
| Tier 1 (Highest) | Uterine/endometrial cancer, Stage 3 or 4, younger plaintiff | $300,000 to $1,500,000+ |
| Tier 2 | Uterine/endometrial cancer, Stage 1 or 2 | $100,000 to $500,000 |
| Tier 3 | Ovarian cancer, any stage | $75,000 to $400,000 |
| Tier 4 | Uterine fibroids (if accepted) | $10,000 to $50,000 |
These are estimates drawn from mass tort benchmarks. Actual settlement amounts depend on what happens at trial, how many cases settle together, and the financial capacity of each defendant.
Attorney fees and case costs are typically deducted from any settlement, usually between 30% and 40% of the gross recovery. Net amounts to plaintiffs will be lower than the gross figures above.
Hair Relaxer Lawsuit Payout Per Person: How Individual Amounts Are Calculated
The payout per person in the hair relaxer lawsuit is not a flat amount. It is calculated based on several personal factors tied to your specific injury and circumstances.
Think of it like personal injury law, which it is. Two people with the same diagnosis can receive very different amounts depending on their age, the severity of their illness, the treatments they went through, and whether the cancer affected their ability to work or care for their family.
Factors that increase individual payout:
- Later-stage cancer diagnosis (Stage 3 or 4)
- Younger age at diagnosis (higher lost earnings and life impact)
- Extensive treatment history: surgery, chemotherapy, radiation
- Documented loss of income or career disruption
- Death of plaintiff (wrongful death claims carry higher value)
- Long history of relaxer use with strong documentation
- Clear medical records showing no alternative causes
Factors that may reduce individual payout:
- Diagnosis of a lower-tier condition (fibroids vs. cancer)
- Multiple significant comorbidities that complicate causation
- Older age at diagnosis with shorter life expectancy impact
- Weak product use documentation
- Late filing or statute of limitations issues
No calculator spits out your number automatically. The valuation is negotiated between attorneys, and in trial cases, decided by juries.
Hair Relaxer Lawsuit Evidence Requirements: What You Need to Prove Your Claim
To file a viable hair relaxer claim, you need evidence of both product use and medical diagnosis. The stronger your documentation, the stronger your case.
Many women are discouraged because they think they cannot prove they used specific products decades ago. That is not necessarily true. Courts accept personal testimony, family witness statements, and circumstantial evidence like old photographs or receipts. Perfect documentation is not required, though it helps.
Evidence you should gather now:
- Medical records confirming your cancer diagnosis (pathology reports, surgical reports)
- Treatment records: chemotherapy, radiation, surgery history
- Prescription records for cancer-related medications
- Salon records or receipts if you had relaxers applied professionally
- Photographs from social media, family albums, or personal archives showing your appearance during years of use
- Receipts or purchase records for at-home relaxer kits
- Written statements from family members or friends who witnessed your use
- Employment records if cancer treatment caused you to miss work
| Evidence Type | Strength Level |
|---|---|
| Pathology report (cancer diagnosis) | Essential |
| Salon records showing relaxer applications | Strong |
| Purchase receipts for home use kits | Strong |
| Personal testimony of use history | Acceptable |
| Family witness statements | Acceptable |
| Photographs showing processed/relaxed hair | Supporting |
| Employment records showing lost wages | Supporting (damages) |
You do not need all of these. You need enough to establish a credible picture of regular, long-term product use and a resulting diagnosis.
How to File a Hair Relaxer Lawsuit Claim in 2026
Filing a hair relaxer lawsuit claim in 2026 starts with contacting a mass tort attorney who is already working within the MDL.
You do not file a claim directly with the court on your own. This is not a simple online form. These are complex personal injury cases that require attorney representation. Most mass tort attorneys handling these cases take them on contingency, meaning you pay nothing upfront. They collect a percentage of your recovery only if you win or settle.
Step-by-step filing process:
- Contact a mass tort law firm handling hair relaxer cases
- Complete an intake questionnaire (usually online or by phone)
- Provide your medical records and product use history
- Attorney reviews your case for eligibility
- If accepted, attorney files your case in the MDL or state court
- Your case is managed within the MDL pretrial process
- You participate in discovery if required (answer questions, provide documents)
- Case proceeds toward settlement discussions or bellwether trial
Key Takeaway: Filing a claim is free upfront if you work with a contingency-fee attorney. The process takes months to years, but you do not need to navigate the court system alone or pay out of pocket to get started.
The single biggest mistake people make is waiting. Statute of limitations deadlines are real, and missing them ends your claim permanently regardless of how strong it is.
Hair Relaxer Lawsuit Filing Deadline 2026: Statute of Limitations Explained
The filing deadline for a hair relaxer claim depends on the state where you live and the date of your diagnosis.
Statutes of limitations for personal injury and product liability claims typically run two to three years from the date of diagnosis or from the date you reasonably discovered that the product caused your illness. This is called the “discovery rule.”
State statute of limitations (general estimates):
| State | Typical Limit | Notes |
|---|---|---|
| California | 2 years | From discovery of injury |
| New York | 3 years | From date of injury |
| Texas | 2 years | From date of discovery |
| Illinois | 2 years | From date of discovery |
| Florida | 2 years | From diagnosis date |
| Pennsylvania | 2 years | From discovery |
| Ohio | 2 years | Product liability standard |
These are general figures. Your specific state’s law, and the specific facts of your case, control the actual deadline.
If you were diagnosed several years ago and have not yet filed, do not assume you have missed the window. An attorney can evaluate whether the discovery rule or other exceptions extend your deadline. But the window does close, and 2026 is not the year to sit on a potential claim.
Frequently Asked Questions
What is the current status of the hair relaxer lawsuit in 2026?
The hair relaxer lawsuit is in active pretrial and early trial phases inside MDL No. 3060 before Judge Mary M. Rowland in the Northern District of Illinois.
Bellwether trials are scheduled for 2026, with Daubert hearings and summary judgment motions playing out in the first half of the year.
No global settlement has been announced, but the litigation is at the stage where settlement pressure typically builds after first verdicts come in.
How much money can you get from the hair relaxer lawsuit?
There is no fixed amount, but legal analysts estimate settlement ranges from roughly $75,000 to over $1,000,000 depending on diagnosis severity and personal circumstances.
Tier 1 cases involving advanced-stage uterine or endometrial cancer in younger women are estimated at the highest end.
These are estimates only. Actual payouts depend on bellwether trial results and individual case negotiations.
Who qualifies for the hair relaxer lawsuit?
You likely qualify if you used chemical hair relaxer products at least four times per year over a sustained period and were later diagnosed with uterine cancer, endometrial cancer, or ovarian cancer.
Product use must involve brands made by named defendant companies, which include L’Oreal, Revlon, Strength of Nature, and others.
Your case strength improves with documented product use and a clear medical record showing diagnosis.
What evidence do you need to file a hair relaxer claim?
The most important pieces of evidence are your medical records confirming the cancer diagnosis and some form of documentation showing you used relaxer products regularly.
Salon records, purchase receipts, personal testimony, and family witness statements are all acceptable forms of product use evidence.
You do not need perfect records to file. An attorney can help you assess what you have and build your claim from there.
What is the filing deadline for the hair relaxer lawsuit in 2026?
The deadline depends on your state’s statute of limitations, which typically runs two to three years from the date of your diagnosis or the date you discovered the connection between the product and your illness.
Some states apply a discovery rule that may extend your deadline if you only recently learned about the link.
The safest move is to contact an attorney immediately, because missing the deadline permanently eliminates your right to file, no matter how strong your claim is.
Where Things Go From Here
The hair relaxer lawsuit in 2026 is at an inflection point. Bellwether trials will produce verdicts. Those verdicts will drive settlement talks. And thousands of women who have been waiting for years will finally get answers about what their case is worth.
If you used chemical hair relaxers and were diagnosed with uterine, endometrial, or ovarian cancer, your window to file is still open in most states. The case has real scientific backing, real defendants with real money, and a federal court moving it toward resolution.
Do not wait for the settlement announcement to act. By the time a settlement is finalized, deadlines may have passed for late filers. Reach out to a mass tort attorney now, gather your medical records, and find out where you stand.
